ArticleAnnals of medicine2026

Clinical and inflammatory determinants of successful abrocitinib dose reduction in atopic dermatitis: a real-world cohort study with implications for treatment optimization.

Yu Wang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.